Skip to content

Clinical trials

Phase 2/3 Stomach Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 2/3 Country / region: Germany Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20101
20122
20162
20191
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest2
Auron Healthcare GmbH1
Australasian Gastro-Intestinal Trials Group1
Bristol-Myers Squibb1
Hoffmann-La Roche1
Krankenhaus Nordwest1
MacroGenics1
University Hospital Tuebingen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms9
Colonic Neoplasms1
Esophageal Neoplasms1
Gallbladder Neoplasms1
Gastrointestinal Neoplasms1
Genital Neoplasms, Female1
Liver Neoplasms1
Lung Neoplasms1
Pancreatic Neoplasms1
Pathologic Complete Response1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.